Parties d'ouvrages collectifs (4)
  1. 1. Gelfand, E. E., Simon, D., Simon, H.-U., Thomas, P. A., Busse, W. W., Nair, P., Gauvreau, G. G., Denburg, J. J., Bivins-Smith, E. E., Jacoby, D., Davis, B. B., Rothenberg, M., Khoury, P., Klion, A., Lotfi, R., Spada, N., Lotze, M. T., Schleimer, R. R., Kato, A., Kern, R., Lavigne, M. M., Eppihimer, M. M., Roufosse, F., Le Moine, A., Massart, A., Benghiat, F., Lemaitre, P., Krahn, M., Bartoli, M., & Levy, N. (2013). Eosinophils in Human Disease. In Eosinophils in Health and Disease (pp. 431-536). Elsevier Inc. doi:10.1016/B978-0-12-394385-9.00013-4
  2. 2. Charbonnier, L.-M., Vokaer, B., Lemaitre, P., & Le Moine, A. (2013). Th17 cells in transplantation: Actors or innocent bystanders? In IL-17, IL-22 and Their Producing Cells: Role in Inflammation and Autoimmunity (pp. 177-185). Springer Basel. doi:10.1007/978-3-0348-0522-3_13
  3. 3. Hougardy, J.-M., Massart, A., & Le Moine, A. (2012). La fonction rénale. In M. Manto (Ed.), Physiologie et physiopathologie humaine: des principes de physiologie à la clinique incluant des exercices corrigés. Sauramps Médical.
  4. 4. Roufosse, F., Massart, A., Benghiat, F., Lemaitre, P., & Le Moine, A. (2012). Eosinophils and Allograft Rejection. In J. L. Lee & H. F. Rosenberg (Eds.), Eosinophils in Health and Disease. Academic Press, Elsevier.
    5.   Articles dans des revues avec comité de lecture (113)
  5. 1. Diamante Chiodini, B., Guillaume-Gentil, P., Vanhomwegen, C., Hennaut, E., Lolin, K., Tram, N., Le Moine, A., & Ismaili, K. (2024). BK Polyomavirus in Pediatric Renal Transplantation—What We Know and What We Do Not. Biomedicines, 12(5), 1093. doi:10.3390/biomedicines12051093
  6. 2. Van Meerhaeghe, T., Murakami, N., Le Moine, A., Brouard, S., Sprangers, B., & Degauque, N. (2024). Fine-tuning tumor- and allo-immunity: advances in the use of immune checkpoint inhibitors in kidney transplant recipients. Clinical Kidney Journal, 17(4), sfae061. doi:10.1093/ckj/sfae061
  7. 3. Gemander, N., Kemlin, D., Depickère, S., Kelkar, N. N., Pannus, P., Sharma, S., Waegemans, A., Olislagers, V., Georges, D., Dhondt, E., Braga, M., Heyndrickx, L., Michiels, J., Thiriard, A., Lemy, A., Vandevenne, M., Goossens, M. M., Matagne, A., Desombere, I., Ariën, K., Ackerman, M. M., Le Moine, A., & Marchant, A. (2024). Hybrid Immunity Overcomes Defective Immune Response to COVID-19 Vaccination in Kidney Transplant Recipients. Kidney International Reports, 9(3), 635-648. doi:10.1016/j.ekir.2023.12.008
  8. 4. Van Meerhaeghe, T., & Le Moine, A. (2023). Editorial: Nephrotoxicity of immune checkpoint inhibitors. Frontiers in Medicine, 10, 1347101. doi:10.3389/fmed.2023.1347101
  9. 5. Van Meerhaeghe, T., Baurain, J.-F., Bechter, O., Orte Cano, C., Del Marmol, V., Devresse, A., Doubel, P., Hanssens, M., Hellemans, R., Lienard, D., Rutten, A., Sprangers, B., Le Moine, A., & Aspeslagh, S. (2022). Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients. Nephrology frontier, 2, 1041819. doi:10.3389/fneph.2022.1041819
  10. 6. Van Meerhaeghe, T., Baurain, J.-F., Bechter, O., Orte Cano, C., Del Marmol, V., Devresse, A., Doubel, P., Hanssens, M., Hellemans, R., Lienard, D., Rutten, A., Sprangers, B., Le Moine, A., & Aspeslagh, S. (2022). Corrigendum: Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients (Néphrologie & Thérapeutique, (2022), 18, 5, (372), 10.1016/j.nephro.2022.07.395). Nephrology frontier, 2, 1129134. doi:10.3389/fneph.2022.1129134
  11. 7. Hellemans, R., Kramer, A., De Meester, J. M. J. J., Collart, F., Kuypers, D., Jadoul, M., Van Laecke, S., Le Moine, A., Krezsinski, J. M., Wissing, K. M., Luyckx, K., van Meel, M., de Vries, E., Tieken, I., Vogelaar, S., Samuel, U., Abramowicz, D., Stel, V. V., & Jager, K. K. (2021). Does kidney transplantation with a standard or expanded criteria donor improve patient survival? Results from a Belgian cohort. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 36(5), 918-926. doi:10.1093/ndt/gfab024
  12. 8. Catalano, C., Servais, S., Bonvoisin, C., Couturier, B., Hildebrand, M., Etienne, I., Meuris, C., Goffard, J.-C., Wissing, K. M., Goldman, M., & Le Moine, A. (2021). Preemptive Antibody Therapy for Vaccine Breakthrough SARS-CoV-2 Infection in Immunocompromised Patients. Transplantation, 105(12), e282. doi:10.1097/TP.0000000000003942
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Suivant >>